Navigation Links
Alseres Pharmaceuticals, Inc. Raises $5 Million
Date:6/30/2008

HOPKINTON, Mass., June 30 /PRNewswire-FirstCall/ -- On June 25, 2008, Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE), a biopharmaceuticals company engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system, entered a into Convertible Promissory Note Purchase Agreement, with Robert Gipson (the "Lender"), pursuant to which the Company may borrow up to aggregate principal amount of $5,000,000. Pursuant to the Purchase Agreement, the Company issued a convertible promissory note to the Lender in the aggregate principal amount of $5,000,000 (the "Note").

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

According to the terms of the Purchase Agreement, the Lender may elect to convert all or a portion of the outstanding principal and accrued interest under the Note (the "Total Converted Balance") into (i) shares of the Company's common stock at a conversion price of $2.50 per share or (ii) into the right to receive from the Company the following payments related to the Company's molecular imaging products: for each $1,000,000 of Total Converted Balance, (A) 2% of Pre-Commercial Income; plus (B) a royalty at a rate of 0.5% of Net Sales of Molecular Imaging Products (each as defined in the Purchase Agreement).

Robert Gipson, who serves as a Senior Director of Ingalls & Snyder LLC and a General Partner of Ingalls & Snyder Value Partners, L.P., served as a director of the Company from June 15, 2004 until October 28, 2004.

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (Nasdaq:

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
2. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
3. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
4. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
5. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
6. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
7. Scimitar Equity, LLC Initiates Coverage Review of VioQuest Pharmaceuticals, Inc.
8. Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
9. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
10. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
11. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ... today reported results of its Oral Amphotericin B ... reservoirs.  The study, conducted by ImmuneCarta®, the immune ... vitro effectiveness of Oral Amp B in ... in individuals despite intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... According to the new ... (Municipal Wastewater Treatment and Industrial Wastewater Treatment), By ... By Configuration (Internal/Submerged and External/Sidestream), and By Region-Trends ... market for membrane bioreactor systems is projected to ... CAGR of 15.28% between 2014 and 2019. ...
(Date:8/16/2014)... NY (PRWEB) August 16, 2014 ... industry provide guidance and advisory services to ... and technical issues. Industry services are highly diverse ... Therefore, industry services range from geological and geophysical ... plans. “Consequently, over the past five years, the ...
Breaking Biology Technology:iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 3
... CPHD ) today announced that it will report financial results ... 30, 2009, after the close of the market. , , ... Time on Thursday, July 30, 2009, to discuss the results. ... www.cepheid.com/investors at least 15 minutes before the scheduled ...
... June 25, 2009 Veritide Ltd., a developer of ... new independent data to be presented at the Biodetection ... Ceeker (pronounced "seeker") portable bacterial detection device in discriminating ... data show that in over two weeks of testing ...
... N.J. Dr. Frank Fisher, an Assistant Professor of ... and Co-Director of the Graduate Nantoechnology Program at Stevens ... two 2009 Ferdinand P. Beer and E. Russell Johnston ... of Engineering Education (ASEE). , Fisher was selected on ...
Cached Biology Technology:Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 2Novel handheld device detects anthrax with outstanding accuracy and reliability 2Novel handheld device detects anthrax with outstanding accuracy and reliability 3
(Date:8/19/2014)... analyzed concentrations of African dust transported to South ... spring. These research findings offer new insight on ... of African dust, including the climate change-induced human ... increased African dust emissions in the coming decades., ... School of Marine and Atmospheric Science and colleagues ...
(Date:8/19/2014)... release is available in German . ... new information about the metabolism of plants can switch ... Erich Kombrink from the Max Planck Institute for Plant ... University of Duisburg-Essen adopt a different approach. They identify ... process like brake pads and prevent the downstream reactions. ...
(Date:8/19/2014)... DIEGO, Calif. (August 19, 2014) Daylight was breaking ... MY Hanse Explorer. Between sips, about a dozen scientists ... and slip below the surface to collect water samples ... would tinker with the whirring gizmos and delicate machinery ... single goal: Be the first research group to bring ...
Breaking Biology News(10 mins):Study of African dust transport to South America reveals air quality impacts 2Researchers block plant hormone 2Researchers block plant hormone 3Sequencing at sea 2Sequencing at sea 3
... WORCESTER, Mass. A Worcester Polytechnic Institute (WPI) research ... the National Institutes of Health (NIH) to continue a ... to tools that will enable physicians to predict the ... heart attacks and strokes. Led by Dalin Tang, PhD, ...
... of bacteria can produce a lethal chemical that keeps ... the growth of nearby colonies and even killing some ... for themselves, even when the encroaching colony is closely ... is a superorganism, a multicellular organism with it,s own ...
... German . , In the coming decades, ... living conditions for plants, whereby major regional differences may be ... future provide habitats for additional species, and in arid and ... plant diversity will deteriorate. This is the conclusion reached in ...
Cached Biology News:WPI receives $1.4 million from NIH for pioneering work on arterial plaque and cardiovascular disease 2WPI receives $1.4 million from NIH for pioneering work on arterial plaque and cardiovascular disease 3Colonies of bacteria fight for resources with lethal protein 2Global warming threatens plant diversity 2Global warming threatens plant diversity 3
...
... measures NOS activity by monitoring the conversion ... is simple, sensitive, and specific for NOS ... crude and purified enzyme preparations. The kit ... total reactions. Radiolabeled arginine and NADPH are ...
Human TSLP MAb (Clone 258136)...
Human Complement Component C5a MAb (Clone 295003)...
Biology Products: